$33.74
9.58% yesterday
Nasdaq, Dec 03, 10:00 pm CET
ISIN
US53635D2027
Symbol
LQDA

Liquidia Technologies, Inc. Stock price

$33.74
+8.52 33.78% 1M
+17.21 104.11% 6M
+21.98 186.90% YTD
+22.48 199.64% 1Y
+28.56 551.35% 3Y
+30.82 1,055.48% 5Y
+22.64 203.96% 10Y
+22.64 203.96% 20Y
Nasdaq, Closing price Wed, Dec 03 2025
+2.95 9.58%
ISIN
US53635D2027
Symbol
LQDA
Industry

Key metrics

Basic
Market capitalization
$2.9b
Enterprise Value
$3.0b
Net debt
$35.0m
Cash
$157.5m
Shares outstanding
86.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
42.4 | 40.0
EV/Sales
42.9 | 40.5
EV/FCF
negative
P/B
133.1
Financial Health
Equity Ratio
33.5%
Return on Equity
-169.3%
ROCE
-62.0%
ROIC
-
Debt/Equity
8.7
Financials (TTM | estimate)
Revenue
$69.2m | $73.4m
EBITDA
$-105.5m | $-142.8m
EBIT
$-107.3m | $-126.6m
Net Income
$-121.9m | $-140.9m
Free Cash Flow
$-107.8m
Growth (TTM | estimate)
Revenue
343.4% | 424.2%
EBITDA
5.4% | -17.8%
EBIT
3.9% | -4.4%
Net Income
-2.0% | -8.0%
Free Cash Flow
-16.6%
Margin (TTM | estimate)
Gross
89.1%
EBITDA
-152.5% | -194.6%
EBIT
-155.0%
Net
-176.0% | -192.0%
Free Cash Flow
-155.8%
More
EPS
$-1.4
FCF per Share
$-1.2
Short interest
23.0%
Employees
170
Rev per Employee
$80.0k
Show more

Is Liquidia Technologies, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Liquidia Technologies, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Liquidia Technologies, Inc. forecast:

13x Buy
87%
1x Hold
7%
1x Sell
7%

Analyst Opinions

15 Analysts have issued a Liquidia Technologies, Inc. forecast:

Buy
87%
Hold
7%
Sell
7%

Financial data from Liquidia Technologies, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
69 69
343% 343%
100%
- Direct Costs 7.54 7.54
37% 37%
11%
62 62
511% 511%
89%
- Selling and Administrative Expenses 130 130
68% 68%
188%
- Research and Development Expense 39 39
12% 12%
56%
-106 -106
5% 5%
-152%
- Depreciation and Amortization 1.73 1.73
1,822% 1,822%
2%
EBIT (Operating Income) EBIT -107 -107
4% 4%
-155%
Net Profit -122 -122
2% 2%
-176%

In millions USD.

Don't miss a Thing! We will send you all news about Liquidia Technologies, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Liquidia Technologies, Inc. Stock News

Neutral
Seeking Alpha
15 days ago
Liquidia Corporation ( LQDA ) Jefferies London Healthcare Conference 2025 November 18, 2025 8:00 AM EST Company Participants Roger Jeffs - CEO & Director Michael Kaseta - COO & CFO Conference Call Participants Amy Li - Jefferies LLC, Research Division Presentation Amy Li Jefferies LLC, Research Division Hi, everyone, thanks so much for attending the Liquidia fireside chat. Day 2 of the conferen...
Positive
The Motley Fool
17 days ago
California-based TCG Crossover Management added 1.7 million shares of Liquidia for an estimated $38.9 million in the third quarter. The position represented 1.9% of reported assets at quarter-end.
Positive
Seeking Alpha
29 days ago
Liquidia Corporation has just posted strong Q3 results after a recent FDA approval, and the commercial launch of YUTREPIA is showing solid early sales traction. The Q3 earnings beat has triggered numerous upward price target revisions for LQDA stock from analyst firms. Liquidia has a solid balance sheet and is well on its way to consistent profitability.
More Liquidia Technologies, Inc. News

Company Profile

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC.

Head office United States
CEO Roger Jeffs
Employees 170
Founded 2004
Website www.liquidia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today